Alector, Inc. Basic Shares Outstanding (Weighted Average)
Alector, Inc. (ALEC) reported Basic Shares Outstanding (Weighted Average) of 111.22 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- Alector, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 111.22M shares, a 10.81% increase year-over-year.
- Alector, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 110.59M shares, a 11.26% increase year-over-year.
- Alector, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 109.59M shares, a 11.45% increase year-over-year.
- Alector, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 102.60M shares, a 5.21% increase year-over-year.
- Alector, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 103.00M shares, a 6.64% increase from fiscal 2024.
- Alector, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 96.59M shares, a 15.35% increase from fiscal 2023.
- Alector, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 83.73M shares, a 1.54% increase from fiscal 2022.
- Alector, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 82.47M shares, a 2.55% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 111.22M shares 10-Q · filed 2026-08-06 | 110.91M shares 10-Q · filed 2026-08-06 | 110.47M shares derived: average of 3 quarters · filed 2026-08-06 | 108.50M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 110.59M shares 10-Q · filed 2026-05-07 | 110.09M shares derived: average of 2 quarters · filed 2026-05-07 | 107.59M shares derived: average of 3 quarters · filed 2026-05-07 | 105.79M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 109.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 106.10M shares derived: average of 2 quarters · filed 2026-02-25 | 104.19M shares derived: average of 3 quarters · filed 2026-08-06 | 103.00M shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 102.60M shares 10-Q · filed 2025-11-06 | 101.48M shares derived: average of 2 quarters · filed 2026-08-06 | 100.80M shares 10-Q · filed 2025-11-06 | 100.17M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 100.37M shares 10-Q · filed 2026-08-06 | 99.89M shares 10-Q · filed 2026-08-06 | 99.37M shares derived: average of 3 quarters · filed 2026-08-06 | 98.91M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 99.40M shares 10-Q · filed 2026-05-07 | 98.86M shares derived: average of 2 quarters · filed 2026-05-07 | 98.42M shares derived: average of 3 quarters · filed 2026-05-07 | 97.98M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 98.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 97.93M shares derived: average of 2 quarters · filed 2026-02-25 | 97.51M shares derived: average of 3 quarters · filed 2026-02-25 | 96.59M shares 10-K · filed 2026-02-25 |
| 2024-09-30 | 97.52M shares 10-Q · filed 2025-11-06 | 97.10M shares derived: average of 2 quarters · filed 2025-11-06 | 96.01M shares 10-Q · filed 2025-11-06 | 93.10M shares derived: average of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | 96.67M shares 10-Q · filed 2025-08-07 | 95.24M shares 10-Q · filed 2025-08-07 | 91.63M shares derived: average of 3 quarters · filed 2025-08-07 | 89.70M shares derived: average of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 93.81M shares 10-Q · filed 2025-05-08 | 89.10M shares derived: average of 2 quarters · filed 2025-05-08 | 87.38M shares derived: average of 3 quarters · filed 2025-05-08 | 86.41M shares derived: average of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 84.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 84.16M shares derived: average of 2 quarters · filed 2025-02-26 | 83.94M shares derived: average of 3 quarters · filed 2025-02-26 | 83.73M shares 10-K · filed 2025-02-26 |
| 2023-09-30 | 83.93M shares 10-Q · filed 2024-11-06 | 83.71M shares derived: average of 2 quarters · filed 2024-11-06 | 83.51M shares 10-Q · filed 2024-11-06 | 83.32M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | 83.50M shares 10-Q · filed 2024-08-07 | 83.19M shares 10-Q · filed 2024-08-07 | 83.12M shares derived: average of 3 quarters · filed 2025-02-26 | 82.99M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | 83.10M shares 10-Q · filed 2024-05-08 | 82.93M shares derived: average of 2 quarters · filed 2025-02-26 | 82.82M shares derived: average of 3 quarters · filed 2025-02-26 | 82.72M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | 82.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 82.68M shares derived: average of 2 quarters · filed 2025-02-26 | 82.59M shares derived: average of 3 quarters · filed 2025-02-26 | 82.47M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 82.60M shares 10-Q · filed 2023-11-07 | 82.50M shares derived: average of 2 quarters · filed 2023-11-07 | 82.37M shares 10-Q · filed 2023-11-07 | 82.16M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 82.39M shares 10-Q · filed 2023-08-03 | 82.25M shares 10-Q · filed 2023-08-03 | 82.01M shares derived: average of 3 quarters · filed 2024-02-27 | 81.75M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 82.10M shares 10-Q · filed 2023-05-04 | 81.81M shares derived: average of 2 quarters · filed 2024-02-27 | 81.53M shares derived: average of 3 quarters · filed 2024-02-27 | 81.09M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 81.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 81.24M shares derived: average of 2 quarters · filed 2024-02-27 | 80.76M shares derived: average of 3 quarters · filed 2024-02-27 | 80.42M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 80.96M shares 10-Q · filed 2022-11-08 | 80.38M shares derived: average of 2 quarters · filed 2022-11-08 | 80.05M shares 10-Q · filed 2022-11-08 | |
| 2021-06-30 | 79.79M shares 10-Q · filed 2022-08-04 | 79.60M shares 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | 79.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 78.89M shares derived: average of 2 quarters · filed 2023-02-28 | 77.76M shares 10-K · filed 2023-02-28 | |
| 2020-09-30 | 78.77M shares 10-Q · filed 2021-11-04 | 77.34M shares 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |